Introduction/Overview The pharmacology of drugs of abuse encompasses the study of substances that are used non-medically for their psychoactive effects, leading to a high potential for dependence and addiction. This field integrates principles of neuropharmacology, pharmacokinetics, and clinical medicine to understand how these substances alter brain function and behavior. Substance use disorders represent a significant … Read more
Introduction/Overview The pharmacological modulation of central nervous system (CNS) arousal and cognitive function represents a critical area of therapeutics with applications spanning neuropsychiatry, neurology, and general medicine. CNS stimulants and nootropics comprise a diverse group of agents that enhance cortical activity, alertness, attention, and various domains of executive function. The clinical relevance of these drugs … Read more
Introduction/Overview Central nervous system (CNS) stimulants and nootropics constitute a pharmacologically diverse group of agents that enhance cortical arousal, attention, and cognitive function. These drugs hold significant clinical importance in the management of several neurological and psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and cognitive impairment. The therapeutic application of these substances is balanced by … Read more
Introduction/Overview Alzheimer’s disease represents the most prevalent form of dementia, characterized by progressive neurodegeneration leading to cognitive decline, functional impairment, and behavioral disturbances. The pharmacological management of this condition is centered on symptomatic treatment, with emerging therapies targeting underlying disease pathology. The clinical relevance of these agents is substantial, as they aim to modify the … Read more
Introduction/Overview Parkinsonism constitutes a clinical syndrome characterized by the cardinal motor features of bradykinesia, resting tremor, rigidity, and postural instability. The most prevalent cause is idiopathic Parkinson’s disease (PD), a progressive neurodegenerative disorder. The primary neuropathological hallmark of PD is the degeneration of dopaminergic neurons within the substantia nigra pars compacta, leading to a profound … Read more
Introduction/Overview Parkinsonism constitutes a clinical syndrome characterized by the cardinal motor features of bradykinesia, resting tremor, rigidity, and postural instability. While idiopathic Parkinson’s disease (PD) is the most prevalent cause, parkinsonism may also arise from other neurodegenerative disorders, vascular insults, or exposure to certain drugs. The neuropathological hallmark of PD is the progressive degeneration of … Read more
Introduction/Overview Barbiturates represent a historic class of central nervous system depressant drugs whose clinical use has been largely supplanted by safer alternatives, yet whose pharmacological principles remain foundational to neuropharmacology. Derived from barbituric acid, these agents were once the cornerstone of sedative, hypnotic, and anticonvulsant therapy throughout much of the 20th century. Their profound depressant … Read more
Introduction/Overview Barbiturates represent a historic class of central nervous system (CNS) depressant drugs, first introduced into clinical practice in the early 20th century. These agents were once the cornerstone of therapy for conditions such as anxiety, insomnia, and seizure disorders. Their clinical use has diminished significantly with the advent of safer alternatives, most notably the … Read more
1. Introduction/Overview Sedative-hypnotic agents constitute a critical class of psychoactive drugs primarily employed to induce sedation, reduce anxiety, and promote sleep. These compounds exert a dose-dependent continuum of central nervous system depression, ranging from mild anxiolysis and sedation at lower doses to hypnosis, general anesthesia, and potentially coma or fatal respiratory depression at higher doses. … Read more
Introduction/Overview Myasthenia gravis represents a prototypical autoimmune disorder of the neuromuscular junction, characterized by fatigable weakness of skeletal muscles. The fundamental pathophysiology involves autoantibodies directed against postsynaptic nicotinic acetylcholine receptors, or less commonly against other key proteins such as muscle-specific kinase or lipoprotein-related protein 4. This immunologic attack reduces the number of functional receptors, impairs … Read more